Patents by Inventor Claude Perol

Claude Perol has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antitumor compositions
    Patent number: 4425348
    Abstract: This invention concerns novel water-soluble compositions of the antitumor agent 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA). More particularly, water-soluble compositions are provided which comprise a mixture of m-AMSA with lactic acid. The compositions enable m-AMSA to be administered as an aqueous solution without the necessity of using dimethylacetamide as a pharmaceutical vehicle.
    Type: Grant
    Filed: August 31, 1981
    Date of Patent: January 10, 1984
    Assignee: Bristol-Myers Company
    Inventors: Murray A. Kaplan, Daniel Bouzard, Claude Perol, Jacques Stemer, Abraham Weber
  • Pharmaceutical formulations of 4'-(9-acridinylamino)-methanesulfon-m-anisidide
    Patent number: 4360523
    Abstract: This invention concerns novel water-soluble compositions of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (m-AMSA). More particularly, water-soluble compositions are provided which comprise a mixture of m-AMSA with lactic acid. The compositions enable m-AMSA to be administered as an aqueous solution without the necessity of using dimethylacetamide as a pharmaceutical vehicle.
    Type: Grant
    Filed: May 16, 1980
    Date of Patent: November 23, 1982
    Assignee: Bristol-Myers Company
    Inventors: Murray A. Kaplan, Daniel Bouzard, Claude Perol, Jacques Stemer, Abraham Weber
  • Crystalline glucoconate salt of m-AMSA and compositions containing same
    Patent number: 4322424
    Abstract: The invention concerns a crystalline monogluconate salt of the antitumor agent 4'-(9-acridinylamino)-methanesulfon-m-anisidide and compositions comprising mixtures of such salt with an organic acid selected from gluconic acid, gluconolactone or mixtures thereof. The novel salt and compositions are characterized in having unexpectedly high water-solubility.
    Type: Grant
    Filed: October 17, 1980
    Date of Patent: March 30, 1982
    Assignee: Bristol-Myers Company
    Inventors: Daniel Bouzard, Claude Perol, Jacques Stemer, Abraham Weber, Edmund S. Granatek